Eton Pharmaceuticals, Inc.: cashflow_investing
| Value | {"amount": -6000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-09-30 |
| Status | current |
| Entity | Eton Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ceb3317d-7e02-4234-9a64-73dddd9bcd7a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-21-028848Retrieved: 2026-08-19T17:30:32.543730+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001710340/cashflow-investing/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ceb3317d-7e02-4234-9a64-73dddd9bcd7a
History
- no predecessors — first report